AMG 623

Generic Name: AMG 623
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20040147Systemic lupus erythematosus (SLE)1A Randomized Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 623 Following Single Dose Administration in Subjects with Systemic Lupus Erythematosus
20040240B-cell Chronic Lymphocytic Leukemia (B-CLL)1A Phase I Open-Label Dose-Finding Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects with B-Cell Chronic Lymphocytic Leukemia Relapsed or Refractory to Purine Nucleoside Treatment
20040250Systemic lupus erythematosus (SLE)1bA Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 623 Following Multi-dose Administration in Subjects with Systemic Lupus Erythematosus